Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -13,685 | N/A |
| Depreciation Amortization | 157 | N/A |
| Accounts payable and accrued liabilities | 2,191 | N/A |
| Other Working Capital | 4,071 | N/A |
| Other Operating Activity | -1,389 | 0 |
| Operating Cash Flow | $-8,655 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,217 | N/A |
| Investing Cash Flow | $-1,217 | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 462 | N/A |
| Common Stock Issued | 41 | N/A |
| Other Financing Activity | 17,980 | 0 |
| Financing Cash Flow | $18,483 | $N/A |
| Beginning Cash Position | 2,012 | N/A |
| End Cash Position | 10,623 | N/A |
| Net Cash Flow | $8,611 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -8,655 | N/A |
| Capital Expenditure | -1,217 | N/A |
| Free Cash Flow | -9,872 | 0 |